Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Toshiaki Ishida"'
Autor:
Shinsuke Mizuno, Yoshiyuki Tsukamura, Shuro Nishio, Toshiaki Ishida, Daiichiro Hasegawa, Yoshiyuki Kosaka, Tadasuke Ooka, Junichiro Nishi, Masashi Kasai
Publikováno v:
Annals of Clinical Microbiology and Antimicrobials, Vol 22, Iss 1, Pp 1-5 (2023)
Abstract Background Tsukamurella spp. are obligate aerobic, gram-positive, non-motile, and slightly acid-fast bacilli belonging to the Actinomycetes family. They share many characteristics with Nocardia, Rhodococcus, Gordonia, and the rapidly growing
Externí odkaz:
https://doaj.org/article/322949b5e8e0482e9a7bf1f58f2c806b
Autor:
Suguru Uemura, Daiichiro Hasegawa, Kenji Kishimoto, Tomoko Fujikawa, Sayaka Nakamura, Aiko Kozaki, Atsuro Saito, Toshiaki Ishida, Takeshi Mori, Kayo Ozaki, Yoshiyuki Kosaka
Publikováno v:
Cancer Medicine, Vol 12, Iss 16, Pp 17018-17027 (2023)
Abstract Background The present study aimed to examine the association between the conditioning intensity and height growth in pediatric patients who underwent allogeneic hematopoietic stem cell transplantation (allo‐HSCT). Methods We reviewed the
Externí odkaz:
https://doaj.org/article/873b9e388a8447c696a56987825d6dfa
Autor:
Naoko Nakatani, Kaung Htet Nay Win, Cho Yee Mon, Tomoko Fujikawa, Suguru Uemura, Atsuro Saito, Toshiaki Ishida, Takeshi Mori, Daiichiro Hasegawa, Yoshiyuki Kosaka, Shotaro Inoue, Akihiro Nishimura, Nanako Nino, Akihiro Tamura, Nobuyuki Yamamoto, Kandai Nozu, Noriyuki Nishimura
Publikováno v:
Biology, Vol 13, Iss 5, p 345 (2024)
Non-high-risk (non-HR) neuroblastoma (NB) patients have excellent outcomes, with more than a 90% survival rate, whereas HR NB patients expect less than a 50% survival rate. Metastatic disease is the principal cause of death among both non-HR and HR N
Externí odkaz:
https://doaj.org/article/4f520bdc7b0e4e60a8476e9f07f04f08
Autor:
Suguru Uemura, Yusuke Demizu, Daiichiro Hasegawa, Tomoko Fujikawa, Shotaro Inoue, Akihiro Nishimura, Ryunosuke Tojyo, Sayaka Nakamura, Aiko Kozaki, Atsuro Saito, Kenji Kishimoto, Toshiaki Ishida, Takeshi Mori, Jyunji Koyama, Atsufumi Kawamura, Yoshinobu Akasaka, Makiko Yoshida, Nobuyoshi Fukumitsu, Toshinori Soejima, Yoshiyuki Kosaka
Publikováno v:
Cancer Medicine, Vol 11, Iss 6, Pp 1502-1510 (2022)
Abstract Introduction This study aimed to evaluate acute toxicities associated with irradiation between the X‐CSI (photon beam craniospinal irradiation) and P‐CSI (proton beam craniospinal irradiation) groups in children with brain tumors. Method
Externí odkaz:
https://doaj.org/article/807760c54e5340ce85834b19ec93fa43
Autor:
Noriyuki Nishimura, Toshiaki Ishida, Isao Yokota, Kimikazu Matsumoto, Hiroyuki Shichino, Hiroyuki Fujisaki, Takeo Sarashina, Takehiko Kamijo, Tetsuya Takimoto, Tomoko Iehara, Tatsuro Tajiri, on behalf of the JCCG Neuroblastoma Committee
Publikováno v:
Biology, Vol 12, Iss 10, p 1350 (2023)
High-risk neuroblastoma (HR-NB) patients remain far from obtaining optimal outcomes, with more than 50% relapse/regrowth rate despite current intensive multimodal therapy. This originated from the activation/proliferation of chemoresistant minimal re
Externí odkaz:
https://doaj.org/article/d8d328b1f5aa4468b06b8f4bc1562bf1
Autor:
Nanako Nino, Toshiaki Ishida, Naoko Nakatani, Kyaw San Lin, Kaung Htet Nay Win, Cho Yee Mon, Akihiro Nishimura, Shotaro Inoue, Akihiro Tamura, Nobuyuki Yamamoto, Suguru Uemura, Atsuro Saito, Takeshi Mori, Daiichiro Hasegawa, Yoshiyuki Kosaka, Kandai Nozu, Noriyuki Nishimura
Publikováno v:
Heliyon, Vol 8, Iss 10, Pp e10978- (2022)
Abstracts: More than half of high-risk neuroblastoma (NB) patients have experienced relapse due to the activation of chemoresistant minimal residual disease (MRD) even though they are treated by high-dose chemotherapy with autologous peripheral blood
Externí odkaz:
https://doaj.org/article/3a34a94c2be7426c9e7b596554231c5f
Autor:
Kyaw San Lin, Suguru Uemura, Khin Kyae Mon Thwin, Naoko Nakatani, Toshiaki Ishida, Nobuyuki Yamamoto, Akihiro Tamura, Atsuro Saito, Takeshi Mori, Daiichiro Hasegawa, Yoshiyuki Kosaka, Nanako Nino, China Nagano, Satoru Takafuji, Kazumoto Iijima, Noriyuki Nishimura
Publikováno v:
Translational Oncology, Vol 14, Iss 8, Pp 101019- (2021)
Abstracts: Neuroblastoma (NB) is the most common extracranial solid tumor in children and originates from sympathoadrenal or Schwann cell precursors derived from neural crest. These neural crest derivatives also constitute the hematopoietic and mesen
Externí odkaz:
https://doaj.org/article/b5191cd2f16a477ca4918ce6767d01a7
Autor:
Akihiro Tamura, Suguru Uemura, Nobuyuki Yamamoto, Atsuro Saito, Aiko Kozaki, Kenji Kishimoto, Toshiaki Ishida, Daiichiro Hasegawa, Haruka Hiroki, Tsubasa Okano, Kohsuke Imai, Tomohiro Morio, Hirokazu Kanegane, Yoshiyuki Kosaka
Publikováno v:
Allergy, Asthma & Clinical Immunology, Vol 14, Iss 1, Pp 1-5 (2018)
Abstract Background X-linked lymphoproliferative disease type 1 (XLP1) is a rare primary immune deficiency, which is caused by SH2D1A gene mutations. XLP1 is commonly associated with Epstein–Barr virus (EBV)-associated hemophagocytic lymphohistiocy
Externí odkaz:
https://doaj.org/article/ee653e6e65a74804b35d140f5150306b
Autor:
Akihiro Tamura, Shotaro Inoue, Takeshi Mori, Jun Noguchi, Sayaka Nakamura, Atsuro Saito, Aiko Kozaki, Toshiaki Ishida, Kay Sadaoka, Daiichiro Hasegawa, Yoshiyuki Kosaka, Masanori Miyanishi
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Despite the growing evidences that immune dysfunction contributes to tumor progression, the prognostic value in patients with neuroblastoma regarding circulating immune blood cell counts has not been well characterized. To answer this, we conducted a
Externí odkaz:
https://doaj.org/article/aaffba76b86b4bf489bffe3ec17a2f65
Autor:
Suguru Uemura, Toshiaki Ishida, Khin Kyae Mon Thwin, Nobuyuki Yamamoto, Akihiro Tamura, Kenji Kishimoto, Daiichiro Hasegawa, Yoshiyuki Kosaka, Nanako Nino, Kyaw San Lin, Satoru Takafuji, Takeshi Mori, Kazumoto Iijima, Noriyuki Nishimura
Publikováno v:
Frontiers in Oncology, Vol 9 (2019)
Neuroblastoma is a common extracranial solid tumor of neural crest (NC) origin that accounts for up to 15% of all pediatric cancer deaths. The disease arises from a transient population of NC cells that undergo an epithelial-mesenchymal transition (E
Externí odkaz:
https://doaj.org/article/83f94d72a23a4670aa80afd5cce07b76